Dakar's Sickle Cell Breakthrough

For decades, Africa has carried the heaviest burden of sickle cell disease and the lightest share of its treatment.

The continent accounts for the overwhelming majority of the world's cases, yet for generations, the medicine that actually works, hydroxyurea has had to travel here from factories in Europe and North America, arriving late, priced high, and often not at all.

That imbalance just cracked.